The antibiotic ketomycin is formed from shikimic acid via chorismic acid and prephenic acid. Phenylalanine and 2',5'-dihydrophenylalanine are not intermediates in the biosynthesis. Degradation of ketomycin derived from [1, acid showed that prephenic acid is converted into ketomycin with stereospecific discrimination between the two enantiotopic edges of the ring, the pro-S-R edge giving rise to the C-2', C-3' side of the cyclohexene ring of ketomycin.
Ketomycin
(R-3-cyclohexenylglyoxylie acid) (1) is an antibiotic metabolite" of Streptornyces antibioticus' 'strains. On a chemically defined medium it inhibits Gram-negative bacteria and
Bacillus subtilis due to its conversion into 3-cyclohexenylglycine, a naturally occurring', 1) false feedback inhibitor of branched chain amino acid biosynthesis',').
In the present communication we report the results of studies on the biosynthesis of ketomycin in S. antibioticus strain TO 99-'.
Experimental
General Methods Radioactive samples were counted in a Beckman LS7000 or 7500 scintillation counter using Aquasol 2 (Beckman) as solvent. Counting efficiencies were determined for each sample using internal standards of ['}C]-and [3H]toluene. Analytical and semipreparative HPLC was carried out on C19 reverse phase columns on a Waters isocratic system consisting of a M-6000 pump, a UK-6 injector and a R401 refractive index detector. Newly synthesized compounds and intermediates in degradations (non-labeled trial runs) were characterized by their NMR (Varian FT-80 and XL-200 instruments) and mass (DuPont 21-492BR instrument) spectra. Feeding Experiments S. antibioticus strain Tu 99=' was obtained from Prof. H. ZAHNER, Tubingen, and was maintained as a spore suspension in 20'//0 glycerol at -20°C.
Slants of inoculum were prepared on Emerson agar (BBL, Becton Dickinson and Co.). Seed cultures and production cultures were grown in 500-ml Er-
THE JOURNAL OF ANTIBIOTICS lenmeyer flasks containing 100 ml of medium consisting of 2 % D-mannitol and 2 % soy bean meal in tap water. These cultures were incubated at 27°C with shaking on a New Brunswick rotary shaker at a speed of 350 rpm. Seed cultures were inoculated with a loopful of spore suspension from a slant and grown for 72 hours; each production flask was then inoculated with 10 ml of seed culture and incubated for 48 hours. Labeled precursors were added as Millipore-sterilized solutions to the production cultures 24 hours after inoculation. The cultures were harvested, Celite 554 (2 g per flask) was added and the broth was filtered through two layers of Whatman No. I filter paper to remove the mycelium. The volume of the filtrate was reduced to 100 ml under vacuum and the solution was adjusted to pH 5 with 2 N HCI, filtered and extracted 3 times with EtOAc. The extract was discarded and the aqueous layer adjusted to pH 2 with 2 N HCI, filtered and extracted 10 times with EtOAc. The extract was dried over sodium sulfate and evaporated to dryness under a vacuum. The residue was subjected to column chromatography (50 g silica gel 60-200 mesh per 1 fermentation broth) with EtOAc -H2O -AcOH, 40: 12: 1 (organic phase) as developing solvent. Fractions of 3 ml were collected and the ketomycin-containing fractions, located by TLC in the same system, were pooled and evaporated to dryness. The crude ketomycin was further purified by preparative TLC (silica gel F,;,, 1 mm thick, solvent as above) eluted with CHC13 -MeOH, 7: 3 and recrystallized from EtOH. Yields of pure isolated material averaged 30 -50 mg/liter culture broth.
Degradation of I Derived from [U-"C]Shikimic Acid The radioactive I was diluted with carrier I and rechromatographed to give 102.5 mg product, which was dissolved in a minimal amount of H2O (<2 ml). The solution was neutralized with I N NaOH and concentrated in vacuo. One drop of HCI, 185 mg p-bromophenacyl bromide and 8.5 ml EtOH were then added and the mixture was refluxed for 2 hours to give, after cooling and addition of 3.5 ml H_O, 411 mg ketomycin p-bromophenacyl ester. This material was recrystallized repeatedly from dilute EtOH until the specific radioactivity was constant. Ketomycin was then regenerated from the ester by hydrolysis with 1 N NaOH (17 hours room temp), extraction from the acidified solution with EtOAc and preparative layer chromatography (silica gel, EtOAc -H2O -HCOOH, 40: 12: 1, organic phase).
The ["C]ketomycin (140.3 mg) was dissolved in 3 ml 40 % NaOH, and 5 ml 15 % H_O., was added dropwise with ice cooling. After stirring at room temperature for 24 hours, the reaction mixture was acidified with cone HCl and extracted with 3 x 15 ml CHCl3. The extract was dried (Na2SO,), concentrated in vacuo, and filtered through a silica gel column (1 x 15 cm). The first 30 ml eluate were collected and evaporated to give 64.9 mg 3-cyclohexenecarboxylic acid as an oil. A small aliquot was converted to the p-bromophenacyl ester for radioactivity measurement.
3-Cyclohexenecarboxylic acid (112.5 mg, diluted 2.6 fold from previous step) was dissolved in 10 ml McOH and hydrogenated over PtO2 (5 mg) for 4.5 hours at room temperature and atmospheric pressure. The catalyst was filtered off, the solution evaporated and the residue dried in a desiccator over PO,.
The residue of 52.8 mg cyclohexanecarboxylic acid was then dissolved in 1.5 ml 100 H,SO, (3 parts cone H.,SO,+1 part fuming H,SO,) and 100 mg NaN3 was added. The reaction was heated to 60°C for 2 hours while the CO. generated was flushed with a gentle stream of N2 (passed successively through wash bottles containing 2 N Ba(OH)2 solution and cone H.. SO,) via a wash bottle with KMnO, solution in 2 N H2SO, into a trap containing 0.2 N Ba(OH)2 solution. The latter was protected from atmospheric CO. by a second trap also containing 0.2 N Ba(OH)2. The resulting BaCO3 was collected by filtration, washed with H2O, EtOH and ether, dried (11.6 mg) and dissolved in 1.5 ml 0.05 M EDTA solution for radioactivity analysis. The reaction mixture was made alkaline and steam distilled (300 ml) into 100 ml 2 N HCI. The aqueous distillate was evaporated to dryness and the residue benzoylated (0.5 ml benzoylchloride in 3 ml pyridine). The product was purified by preparative layer chromatography (silica gel, benzene-ether, 9: 1, developed twice) to give, after recrystallization from ether, 8.3 mg N-benzoylcyclohexylamine.
Degradation of I Derived from [1,6- To a solution of methyl 3-cyclohexenecarboxylate (457 mg) in dry ether stirred at 0°C under an argon atmosphere was added by syringe a solution of phenyllithium (5.2 ml, 9.8 mm) in cyclohexane -ether, 7: 3. After 10 minutes the temperature was raised to ambient and after another hour the mixture was heated to reflux overnight. The reaction mixture was then cooled to room temperature and hydrolyzed by addition of 25 ml H,O. The ether phase was separated and the aqueous layer extracted 3 more times with ether. The combined ether extract was washed with H,O and saturated sodium chloride solution and dried over magnesium sulfate. The yellow oil obtained upon evaporation of the solvent was purified by preparative layer chromatography (silica gel Sil-100 UV,,,, 1 mm thick, hexane as solvent) to give the product in 90 % yield.
Diphenylmethylene-3-cyclohexene:
The tertiary alcohol obtained in the previous step (726 mg) was dissovled in 5 ml dry Me,CO. Cone H,SO, (1 ml per 1.15 mmol reactant) was added dropwise at room temperature to the stirred solution, which turned orange-brown in color. H.,O was then added and the Me.,CO was removed in a vacuum. The aqueous solution was extracted 4 times with CHC13 and the extract was dried and evaporated to dryness. The brownish residue was purified by preparative layer chromatography (silica gel Sil-100 UV2,,, 1 mm thick, hexane) to give the product in 55 % yield.
Succinic Acid: The olefin from the previous step (350 mg) was dissolved in pyridine and added dropwise with stirring to a solution of 3.2 g KMnO, and 20.8 g Na1O, in 30 ml 1 N H3SO,. The mixture eventually turned dark brown with heat and gas evolution and was allowed to stand until it had returned to room temperature. It was filtered and the precipitate washed several times with H.O. The combined filtrates were acidified to pH 2 with 6 N H.,SO, and extracted continuously with ether overnight. The ether extract was evaporated to dryness, the residue redissolved in 20 ml H.O and adjusted to pH 10 with 6 N NaOH. This solution was washed several times with ether, then brought to pH 2 and again extracted continuously with ether overnight. This ether extract was then evaporated and the residue dissolved in 5 ml 0.01 % trifluoroacetic acid. The succinic acid was purified by semipreparative HPLC on an Alltech 5 Ft C13 column with 0.01 % trifluoroacetic acid (pH 2) as solvent at 0.8 ml/minute flow rate (retention time 11 -12 minutes). The collected fractions containing the product were lyophilized to give 22.56 mg pure succinic acid. For the determination of its specific radioactivity, the succinic acid was quantitated both by weight and by HPLC (refractive index detector response) against a standard curve.
Results
Inspection of the structure of ketomycin suggests a biosynthetic origin from shikimic acid. This was confirmed by feeding D-[U-14C]shikimic acid to 24-hour old cultures of S. antibioticus strain TU 99. I was isolated from the cultures 24 hours later and purified to constant specific radioactivity. The results (Table 1 , Expts 1 and 2), 1.64 and 2.87 % incorporation, indicate an effective precursor role of shikimic acid in I biosynthesis.
Shikimic acid could be converted to I by two principally different pathways. One would involve utilization of all 7 carbon atoms of the precursor and extension of the side chain by one additional carbon atom (C,C1+C1). As an alternative, only the 6 ring carbon atoms of shikimic acid might be utilized to generate, via chorismic acid and prephenic acid, a C3C3 compound which would undergo shortening of the side chain by one carbon atom (C,C3-C1).
To determine whether only 6 or all 7 Feeding experiments with these two compounds gave samples of I containing appreciable amounts of radioactivity (Table 1 , Expts 4 and 5). The incorporation rates for chorismic acid and prephenic acid are of the same magnitude, and although they are lower than those of shikimic acid they strongly implicate both compounds in the biosynthetic pathway leading to I. The better incorporation of shikimic acid may reflect differences in permeability or may be due to the greater chemical stability of shikimic acid compared to chorismic acid and prephenic acid.
The involvement of prephenic acid in the biosynthesis of I raises an interesting stereochemical question. Both in the precursor, shikimic acid, and in the product, ketomycin, the six-membered ring is asymmetric, i.e., the two "sides" C-1, C-2, C-3, C-4 and C-i, C-6, C-5, C-4 of the ring are constitutionally different, whereas prephenic acid has a plane of symmetry bisecting C-1 and C-4 of the ring. However, the two "sides" of the prephenic acid ring are enantiotopic and should thus be distinguishable to a chiral the adjacent carbon in the pro-S-R edge of the ring; this follows from the configuration of chorismic acid and the relative stereochemistry of prephenic acid. Depending on the stereochemical pathway by which prephenic acid is processed, I will be labeled either in the 1', 2' or in the 1', 6' positions. The succinic acid resulting from the degradation of I should contain either 50 % (pathway a) or 100 % (pathway b) of the radioactivity of I. If the processing of prephenic acid were non-stereospecific with respect to the two enantiotopic sides of the ring, the succinic acid should contain 75 % of the label. The results ( Table 2 ) of two independent experiments show rather clearly and in good agreement that the succinic acid contains half the label of the ketomycin from which it was derived. The processing of prephenic acid in the formation of I therefore is stereospecific and occurs along pathway a (Fig. 3) .
The above results demonstrate that a biosynthetic pathway must operate in S. antibioticus which converts prephenate, an immediate precursor of a benzene ring, into a hydroaromatic six-membered (Table 1 , Expts 9 and 10). Again, dihydrophenylalanine was incorporated very poorly, whereas shikimic acid was used very efficiently.
Discussion
The results of this study show that ketomycin is formed in S. antibioticus from shikimic acid via chorismic acid and prephenic acid, i.e., only the six ring carbon atoms of shikimic acid are utilized in the formation of I. Prephenic acid is converted into I stereo specifically, the pro-S-R edge of the ring giving rise to carbon atoms 1', 2', 3', 4' of the cyclohexene ring. These findings completely parallel the observations made earlier') about the biosynthesis of dihydrophenylalanine. It was therefore surprising to find that dihydrophenylalanine is not a precursor of I; one would expect that a pathway already widespread in Streptomyces would be utilized to elaborate the ring system of I.
The pathway of ketomycin formation, to the extent it has been established by these studies, is summarized in Fig. 3 . 
